The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNext Regulatory News (NXT)

Share Price Information for Next (NXT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9,200.00
Bid: 9,202.00
Ask: 9,204.00
Change: 10.00 (0.11%)
Spread: 2.00 (0.022%)
Open: 9,180.00
High: 9,216.00
Low: 9,074.00
Prev. Close: 9,190.00
NXT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

18 Sep 2020 15:02

RNS Number : 4794Z
Next PLC
18 September 2020
 

Next plc

Notification of Transactions by Person Discharging Managerial Responsibility and Person Closely Associated With Them

The following awards were granted to executive directors on 18 September 2020 under the Next Long Term Incentive Plan (the "LTIP"):

 

Maximum No. of Shares

Lord Wolfson of Aspley Guise

20,757

Amanda James

12,639

Richard Papp

12,252

Jane Shields

12,252

Under the terms of the LTIP the award comprises a conditional award of shares on the following terms:

· the award will vest following the third anniversary of the date of grant subject to performance targets and continued employment in the Next Group;

 

· a variable percentage of the maximum number of shares above can vest, depending on the relative Total Shareholder Return of Next over a three year period against a comparator group;

 

· for relative performance against the comparator group the percentage vesting will be

 

Relative performance

Percentage vesting

Below median

0%

Median

20%

Upper quintile

100%

 

· as outlined in the Directors' Remuneration Policy approved by shareholders on 14 May 2020, the Remuneration Committee has discretion to override and reduce formulaic outcomes under the LTIP awards should this be considered appropriate in the circumstances;

 

· before any of the awards vest, the Committee must have regard to the performance of the Company in the light of underlying economic and other circumstances, including EPS performance of the Company and of other UK retailers over the period;

 

· to the extent that the performance condition is not met, the award will lapse completely;

 

· to the extent that awards vest, dividend equivalents will be accrued; and

 

· any vesting of these awards granted to executive directors (including dividend equivalents) will be settled in shares and, after payment of tax, the net shares received should be retained for a minimum period of two further years.

 

LTIP awards are made twice a year. The maximum number of shares shown above is 125% of each director's base salary at the date of each grant, divided by NEXT's average share price over the three months prior to the start of the performance period. The total across the two LTIP awards made this year is 225% of each director's base salary.

The following notification made under article 19.1 of the Market Abuse Regulation ("MAR") related to awards granted to executive directors on 18 September 2020 under the LTIP. This announcement is made in accordance with Article 19.3 of MAR.

1

 

Details of the person discharging managerial responsibilities ("PDMR") / person closely associated ("PCA")

 

a)

 

Name

 

1. Lord Wolfson of Aspley Guise

2. Amanda James

3. Richard Papp

4. Jane Shields

2

 

Reason for the notification

a)

 

Position/status

 

1. Chief Executive (PDMR)

2. Group Finance Director (PDMR)

3. Group Merchandise and Operations Director (PDMR)

4. Group Sales and Marketing Director (PDMR)

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

 

Name

 

Next plc

b)

 

LEI

 

213800WQD8ECPZP9PH98

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of £0.10 each - conditional award

 

 

Identification code

GB0032089863

 

 

b)

 

Nature of the transaction

 

 

Conditional award granted of shares under the LTIP. Maximum number of shares as follows:

1. Lord Wolfson of Aspley Guise - 20,757

2. Amanda James - 12,639

3. Richard Papp - 12,252

4. Jane Shields - 12,252

c)

 

Price(s) and volume(s)

 

 

 

 

 

 

Price(s)

Volume(s)

 

Lord Wolfson of Aspley Guise

 

Nil

20,757

 

Amanda James

 

Nil

12,639

 

Richard Papp

 

Nil

12,252

 

Jane Shields

 

Nil

12,252

 

 

 

 

 

 

d)

 

Aggregated information

 

- Aggregated volume

n/a single transactions

 

 

 

 

 

 

 

 

- Price

n/a

 

 

 

 

 

 

e)

 

Date of the transaction

 

 

18 September 2020

f)

 

Place of the transaction

 

Outside a trading venue

 

Seonna Anderson

Company Secretary

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFLFISAIITLII
Date   Source Headline
23rd Apr 20244:31 pmRNSHolding(s) in Company
12th Apr 20242:16 pmRNSAnnual Financial Report
8th Apr 20244:43 pmRNSDirector/PDMR Shareholding
2nd Apr 20247:00 amRNSTotal Voting Rights
26th Mar 20249:50 amRNSHolding(s) in Company
22nd Mar 20242:26 pmRNSDirector/PDMR Shareholding
22nd Mar 20242:24 pmRNSDirector/PDMR Shareholding
22nd Mar 20249:15 amRNSDirector Declaration
21st Mar 20241:15 pmRNSDirector Declaration
21st Mar 202412:50 pmRNSDirector/PDMR Shareholding
21st Mar 20247:00 amRNSNEXT plc Results for the Year Ended January 2024
1st Mar 20249:00 amRNSTotal Voting Rights
19th Feb 20242:27 pmRNSClosed Period Share Repurchase Programme
15th Feb 20244:58 pmRNSTransaction in Own Shares
6th Feb 20245:12 pmRNSTransaction in Own Shares
2nd Feb 20245:10 pmRNSTransaction in Own Shares
1st Feb 20245:20 pmRNSTransaction in Own Shares
1st Feb 20248:00 amRNSTotal Voting Rights
23rd Jan 20245:17 pmRNSTransaction in Own Shares
23rd Jan 20242:44 pmRNSDirector Appointment
22nd Jan 20245:41 pmRNSTransaction in Own Shares
17th Jan 20243:48 pmRNSDirector/PDMR Shareholding - Replacement
17th Jan 202412:00 pmRNSDirector Appointment
5th Jan 202412:00 pmRNSDirector/PDMR Shareholding
5th Jan 202412:00 pmRNSDirector/PDMR Shareholding
4th Jan 20247:00 amRNSTrading Statement
2nd Jan 20248:00 amRNSTotal Voting Rights
19th Dec 20234:45 pmRNSHolding(s) in Company
4th Dec 202310:45 amRNSDirector/PDMR Shareholding
4th Dec 202310:34 amRNSDirector/PDMR Shareholding
1st Dec 20238:00 amRNSTotal Voting Rights
14th Nov 20234:57 pmRNSHolding(s) in Company
13th Nov 202312:30 pmRNSAGM Update
1st Nov 20238:00 amRNSTotal Voting Rights
1st Nov 20237:00 amRNSTrading Statement
19th Oct 20234:00 pmRNSDirector/PDMR Shareholding
18th Oct 20233:00 pmRNSNew Issue and Additional Listing
13th Oct 20233:11 pmRNSAcquisition of FatFace
3rd Oct 20233:19 pmRNSDirector/PDMR Shareholding
2nd Oct 20233:00 pmRNSBoard Changes
2nd Oct 20238:30 amRNSTotal Voting Rights
25th Sep 20235:15 pmRNSDirector/PDMR Shareholding
25th Sep 20235:09 pmRNSDirector/PDMR Shareholding
22nd Sep 20234:00 pmRNSDirector/PDMR Shareholding
21st Sep 20237:00 amRNSResults for the Half Year Ending July 2023
1st Sep 202312:00 pmRNSTotal Voting Rights
1st Sep 20239:30 amRNSAcquisition of Warburg Pincus’ Interest in Reiss
4th Aug 20234:07 pmRNSDirector/PDMR Shareholding
3rd Aug 20237:00 amRNSTrading Statement
1st Aug 20238:34 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.